Invenomic Capital Management’s Snap SNAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,260,794
Closed -$24.2M 157
2026
Q1
$24.2M Buy
5,260,794
+4,424,101
+529% +$26.1M 1.11% 31
2025
Q4
$6.75M Sell
836,693
-738,940
-47% -$5.84M 0.31% 95
2025
Q3
$12.1M Sell
1,575,633
-839,030
-35% -$6.96M 0.59% 62
2025
Q2
$21M Buy
2,414,663
+431,216
+22% +$3.58M 1.19% 25
2025
Q1
$17.3M Buy
1,983,447
+1,275,630
+180% +$13.3M 0.87% 33
2024
Q4
$7.62M Buy
707,817
+488,284
+222% +$5.5M 0.36% 88
2024
Q3
$2.35M Buy
+219,533
New +$2.5M 0.13% 131
2023
Q4
Sell
-540,539
Closed -$4.82M 194
2023
Q3
$4.82M Sell
540,539
-526,095
-49% -$5.5M 0.2% 97
2023
Q2
$12.6M Sell
1,066,634
-12,513
-1% -$126K 0.64% 49
2023
Q1
$12.1M Buy
1,079,147
+27,550
+3% +$289K 0.68% 47
2022
Q4
$9.41M Buy
+1,051,597
New +$10.4M 0.64% 53
2022
Q3
Sell
-464,835
Closed -$6.1M 186
2022
Q2
$6.1M Buy
464,835
+359,637
+342% +$8.2M 0.43% 69
2022
Q1
$3.1M Buy
+105,198
New +$3.8M 0.33% 80

Other funds holding SNAP

Invenomic Capital Management's SNAP Position: Q2 2026 in Review

Invenomic Capital Management sold out of Snap (SNAP) in Q2 2026, closing a stake of 5,260,794 shares — an estimated $24.2M sold.

Invenomic Capital Management first reported a position in SNAP in Q1 2022 and held it in 13 quarters. The position peaked at $24.2M in Q1 2026. 532 funds tracked by Wall St. Rank hold SNAP as of Q2 2026.

  • Invenomic Capital Management reported no remaining Snap position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 5,260,794 Snap shares in Q2 2026, an estimated $24.2M.
  • Invenomic Capital Management first reported a position in Snap in Q1 2022 and held it in 13 quarters.
  • Invenomic Capital Management's Snap position peaked at $24.2M in Q1 2026.
  • 532 funds tracked by Wall St. Rank held Snap as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.